Skip to main content
Erschienen in: Rheumatology International 8/2014

01.08.2014 | Short Communication

Carotid intima-media thickness in children with Kawasaki disease

verfasst von: Raghvendra Singh Meena, Manojkumar Rohit, Anju Gupta, Surjit Singh

Erschienen in: Rheumatology International | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Abstract

Kawasaki disease (KD) is an acute medium vessel vasculitis seen in children. The most significant long-term complication is related to coronary artery abnormalities. Use of intravenous immunoglobulins, however, has led to significant reduction in incidence of coronary aneurysms. What is more alarming is the fact that higher risk of cardiovascular disease is seen in even those children who do not have coronary artery aneurysms during subacute phase. Various factors like abnormal lipid profiles, abnormal vessel wall reactivity and endothelial dysfunction have been implicated for this. Carotid intima-media thickness (cIMT) has been used as a surrogate marker for atherosclerosis. This study was planned to evaluate cIMT in children with KD. Twenty-seven children with diagnosis of KD at least 1 year prior to enrolment were evaluated for cIMT at enrolment and then after 3 months. Fasting lipid profile was done for all patients. Mean cIMT was significantly higher in children with KD compared to controls. In lipid profiles, undesirable HDL-C and triglyceride levels were seen in 2 and 3 children, respectively. Undesirable and borderline LDL-C levels were seen in 1 and 2 patients, respectively. Undesirable and borderline total cholesterol levels were seen in 1 and 3 patients, respectively. Higher cIMTs were seen in our cohort of KD patients. Proatherogenic abnormalities in lipid profile were seen in a few patients. Both abnormalities may predict a higher risk of atherosclerosis in future. The results of this study need to be replicated on a larger study sample and over longer follow-up periods.
Literatur
1.
Zurück zum Zitat Sundel RP, Petty RE (2011) Kawasaki disease. In: Cassidy JT, Petty RE, Laxer RM, Lindsley C (eds) Textbook of pediatric rheumatology, 6th edn. Saunders Elseviers, Philadelphia, pp 505–520CrossRef Sundel RP, Petty RE (2011) Kawasaki disease. In: Cassidy JT, Petty RE, Laxer RM, Lindsley C (eds) Textbook of pediatric rheumatology, 6th edn. Saunders Elseviers, Philadelphia, pp 505–520CrossRef
2.
Zurück zum Zitat Terai M, Shulman ST (1997) Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr 131:888–893PubMedCrossRef Terai M, Shulman ST (1997) Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr 131:888–893PubMedCrossRef
3.
Zurück zum Zitat McCrindle BW, McIntyre S, Kim C, Lin T, Adeli K (2007) Are patients after Kawasaki disease at increased risk for accelerated atherosclerosis? J Pediatr 151:244–248PubMedCrossRef McCrindle BW, McIntyre S, Kim C, Lin T, Adeli K (2007) Are patients after Kawasaki disease at increased risk for accelerated atherosclerosis? J Pediatr 151:244–248PubMedCrossRef
4.
Zurück zum Zitat Niboshi A, Hamaoka K, Sakata K, Yamaguchi N (2008) Endothelial dysfunction in adult patients with a history of Kawasaki disease. Eur J Pediatr 167:189–196PubMedCrossRef Niboshi A, Hamaoka K, Sakata K, Yamaguchi N (2008) Endothelial dysfunction in adult patients with a history of Kawasaki disease. Eur J Pediatr 167:189–196PubMedCrossRef
5.
Zurück zum Zitat Cicala S, Pellegrino T, Storto G, Caprio MG, Paladini R, Mainolfi C, de Leva F, Cuocolo A (2010) Noninvasive quantification of coronary endothelial function by SPECT imaging in children with a history of Kawasaki disease. Eur J Nucl Med Mol Imaging 37:2249–2255PubMedCrossRef Cicala S, Pellegrino T, Storto G, Caprio MG, Paladini R, Mainolfi C, de Leva F, Cuocolo A (2010) Noninvasive quantification of coronary endothelial function by SPECT imaging in children with a history of Kawasaki disease. Eur J Nucl Med Mol Imaging 37:2249–2255PubMedCrossRef
6.
Zurück zum Zitat Mitra A, Singh S, Devidayal, Khullar M (2005) Serum lipids in north Indian children treated for Kawasaki disease. Int Heart J 46: 811–817 Mitra A, Singh S, Devidayal, Khullar M (2005) Serum lipids in north Indian children treated for Kawasaki disease. Int Heart J 46: 811–817
7.
Zurück zum Zitat Cheung YF, Wong SJ, Ho MH (2007) Relationship between carotid intima-media thickness and arterial stiffness in children after Kawasaki disease. Arch Dis Child 92:43–47PubMedCentralPubMedCrossRef Cheung YF, Wong SJ, Ho MH (2007) Relationship between carotid intima-media thickness and arterial stiffness in children after Kawasaki disease. Arch Dis Child 92:43–47PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat Urbina EM, Williams RV, Alpert BS, Collins RT, Daniels SR, Hayman L, Jacobson M, Mahoney L, Mietus-Snyder M, Rocchini A, Steinberger J, McCrindle B, American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young (2009) Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association. Hypertension 54:919–950PubMedCrossRef Urbina EM, Williams RV, Alpert BS, Collins RT, Daniels SR, Hayman L, Jacobson M, Mahoney L, Mietus-Snyder M, Rocchini A, Steinberger J, McCrindle B, American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young (2009) Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association. Hypertension 54:919–950PubMedCrossRef
9.
Zurück zum Zitat Dalla Pozza R, Beyerlein A, Thilmany C, Weissenbacher C, Netz H, Schmidt H, Bechtold S (2011) The effect of cardiovascular risk factors on the longitudinal evolution of the carotid intima medial thickness in children with type 1 diabetes mellitus. Cardiovasc Diabetol 10:53PubMedCentralPubMedCrossRef Dalla Pozza R, Beyerlein A, Thilmany C, Weissenbacher C, Netz H, Schmidt H, Bechtold S (2011) The effect of cardiovascular risk factors on the longitudinal evolution of the carotid intima medial thickness in children with type 1 diabetes mellitus. Cardiovasc Diabetol 10:53PubMedCentralPubMedCrossRef
10.
Zurück zum Zitat Krebs A, Schmidt-Trucksäss A, Alt J, Doerfer J, Krebs K, Winkler K, Schwab KO (2009) Synergistic effects of elevated systolic blood pressure and hypercholesterolemia on carotid intima-media thickness in children and adolescents. Pediatr Cardiol 30:1131–1136PubMedCrossRef Krebs A, Schmidt-Trucksäss A, Alt J, Doerfer J, Krebs K, Winkler K, Schwab KO (2009) Synergistic effects of elevated systolic blood pressure and hypercholesterolemia on carotid intima-media thickness in children and adolescents. Pediatr Cardiol 30:1131–1136PubMedCrossRef
11.
Zurück zum Zitat Loureiro C, Campino C, Martinez-Aguayo A, Godoy I, Aglony M, Bancalari R, Garcia H, Carvajal CA, Fardella C (2012) Positive association between aldosterone-renin ratio and carotid intima-media thickness in hypertensive children. Clin Endocrinol (Oxf). doi:10.1111/j.1365-2265.2012.04503.x Loureiro C, Campino C, Martinez-Aguayo A, Godoy I, Aglony M, Bancalari R, Garcia H, Carvajal CA, Fardella C (2012) Positive association between aldosterone-renin ratio and carotid intima-media thickness in hypertensive children. Clin Endocrinol (Oxf). doi:10.​1111/​j.​1365-2265.​2012.​04503.​x
12.
Zurück zum Zitat Poyrazoğlu HM, Düşünsel R, Yikilmaz A, Narin N, Anarat R, Gündüz Z, Coşkun A, Baykan A, Oztürk A (2007) Carotid artery thickness in children and young adults with end stage renal disease. Pediatr Nephrol 22:109–116PubMedCrossRef Poyrazoğlu HM, Düşünsel R, Yikilmaz A, Narin N, Anarat R, Gündüz Z, Coşkun A, Baykan A, Oztürk A (2007) Carotid artery thickness in children and young adults with end stage renal disease. Pediatr Nephrol 22:109–116PubMedCrossRef
13.
Zurück zum Zitat Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association (2004). Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114: 1708–1733 Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association (2004). Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114: 1708–1733
14.
Zurück zum Zitat Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502PubMed Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502PubMed
15.
Zurück zum Zitat American Academy of Pediatrics (1992) National Cholesterol Education Program: report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 89:525–584 American Academy of Pediatrics (1992) National Cholesterol Education Program: report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 89:525–584
16.
Zurück zum Zitat Kavey RE, Daniels SR, Lauer RM, Atkins DL, Hayman LL, Taubert K, American Heart Association (2003) American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation 107:1562–1566PubMedCrossRef Kavey RE, Daniels SR, Lauer RM, Atkins DL, Hayman LL, Taubert K, American Heart Association (2003) American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation 107:1562–1566PubMedCrossRef
17.
Zurück zum Zitat Ikemoto Y, Ogino H, Teraguchi M, Kobayashi Y (2005) Evaluation of preclinical atherosclerosis by flow-mediated dilatation of the brachial artery and carotid artery analysis in patient with a history of Kawasaki disease. Pediatr Cardiol 26:782–786PubMedCrossRef Ikemoto Y, Ogino H, Teraguchi M, Kobayashi Y (2005) Evaluation of preclinical atherosclerosis by flow-mediated dilatation of the brachial artery and carotid artery analysis in patient with a history of Kawasaki disease. Pediatr Cardiol 26:782–786PubMedCrossRef
18.
Zurück zum Zitat Lee SJ, Ahn HM, You JH, Hong YM (2009) Carotid intima-media thickness and pulse wave velocity after recovery from Kawasaki Disease. Korean Circ J 39:264–269PubMedCentralPubMedCrossRef Lee SJ, Ahn HM, You JH, Hong YM (2009) Carotid intima-media thickness and pulse wave velocity after recovery from Kawasaki Disease. Korean Circ J 39:264–269PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Gupta-Malhotra M, Gruber D, Abraham SS, Roman MJ, Zabriskie JB, Hudgins LC, Flynn PA, Levine DM, Okorie U, Baday A, Schiller MS, Maturi J, Meehan D, Dyme J, Parker TS et al (2009) Atherosclerosis in survivors of Kawasaki disease. J Pediatr 155:572–577PubMedCrossRef Gupta-Malhotra M, Gruber D, Abraham SS, Roman MJ, Zabriskie JB, Hudgins LC, Flynn PA, Levine DM, Okorie U, Baday A, Schiller MS, Maturi J, Meehan D, Dyme J, Parker TS et al (2009) Atherosclerosis in survivors of Kawasaki disease. J Pediatr 155:572–577PubMedCrossRef
20.
Zurück zum Zitat Noto N, Okada T, Yamasuge M, Taniguchi K, Karasawa K, Ayusawa M, Sumitomo N, Harada K (2001) Noninvasive assessment of the early progression of atherosclerosis in adolescents with Kawasaki disease and coronary artery lesions. Pediatrics 107:1095–1099PubMedCrossRef Noto N, Okada T, Yamasuge M, Taniguchi K, Karasawa K, Ayusawa M, Sumitomo N, Harada K (2001) Noninvasive assessment of the early progression of atherosclerosis in adolescents with Kawasaki disease and coronary artery lesions. Pediatrics 107:1095–1099PubMedCrossRef
21.
Zurück zum Zitat Noto N, Okada T, Karasawa K, Ayusawa M, Sumitomo N, Harada K, Mugishima H (2009) Age-related acceleration of endothelial dysfunction and subclinical atherosclerosis in subjects with coronary artery lesions after Kawasaki disease. Pediatr Cardiol 30:262–268PubMedCrossRef Noto N, Okada T, Karasawa K, Ayusawa M, Sumitomo N, Harada K, Mugishima H (2009) Age-related acceleration of endothelial dysfunction and subclinical atherosclerosis in subjects with coronary artery lesions after Kawasaki disease. Pediatr Cardiol 30:262–268PubMedCrossRef
22.
Zurück zum Zitat Sass C, Herbeth B, Chapet O, Siest G, Visvikis S, Zannad F (1998) Intima-media thickness and diameter of carotid and femoral arteries in children, adolescents and adults from the Stanislas cohort: effect of age, sex, anthropometry and blood pressure. J Hypertens 16:1593–1602PubMedCrossRef Sass C, Herbeth B, Chapet O, Siest G, Visvikis S, Zannad F (1998) Intima-media thickness and diameter of carotid and femoral arteries in children, adolescents and adults from the Stanislas cohort: effect of age, sex, anthropometry and blood pressure. J Hypertens 16:1593–1602PubMedCrossRef
23.
Zurück zum Zitat Jourdan C, Wu¨hl E, Litwin M, Fahr K, Trelewicz J, Jobs K, Schenk JP, Grenda R, Mehls O, Tro¨ger J, Schaefer F (2005) Normative values for intima-media thickness and distensibility of large arteries in healthy adolescents. J Hypertens 23:1707–1715PubMedCrossRef Jourdan C, Wu¨hl E, Litwin M, Fahr K, Trelewicz J, Jobs K, Schenk JP, Grenda R, Mehls O, Tro¨ger J, Schaefer F (2005) Normative values for intima-media thickness and distensibility of large arteries in healthy adolescents. J Hypertens 23:1707–1715PubMedCrossRef
Metadaten
Titel
Carotid intima-media thickness in children with Kawasaki disease
verfasst von
Raghvendra Singh Meena
Manojkumar Rohit
Anju Gupta
Surjit Singh
Publikationsdatum
01.08.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 8/2014
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-013-2820-2

Weitere Artikel der Ausgabe 8/2014

Rheumatology International 8/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.